Mariko Noguchi‐Sasaki

Author

Nara Medical University ORCID

Also Known As

MARIKO NOGUCHI-SASAKI,, Mariko Noguchi-Sasaki, Mariko Noguchi‐Sasaki

Publications

266

Citations

H-Index

Concepts

All Affiliations

Nara Medical University Chugai Pharma (United States)GeneCare Research Institute (Japan)

About

Mariko Noguchi‐Sasaki is an author at Nara Medical University specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	149
2	Immunology	4	4	137
3	Allergy	3	3	88
4	Health Sciences	2	2	51
5	Cell Biology	2	2	61

Mariko Noguchi‐Sasaki

Publications

219

Citations

H-Index

Page 1

	Year	Citations
Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice Yusuke Sasaki, Mariko Noguchi‐Sasaki, Hideyuki Yasuno, International Journal of Hematology InflammationHepcidin ExpressionErythropoietin StimulationAutoimmune DiseaseBone Marrow Failure	2012	49
A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X Kenichi Ogiwara, Keiji Nogami, Naoki Matsumoto, International Journal of Hematology ThrombopoiesisThrombosisModified Thrombin GenerationPlasma Coagulation PotentialAutoimmune Disease	2020	37
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells Mariko Noguchi‐Sasaki, Yusuke Sasaki, Yasushi Shimonaka, BMC Cancer	2016	32
An anti‐factor IXa/factor X bispecific antibody, emicizumab, improves ex vivo coagulant potentials in plasma from patients with acquired hemophilia A Masahiro Takeyama, Keiji Nogami, Tomoko Matsumoto, Journal of Thrombosis and Haemostasis InflammationImmunohematologyThrombosisAllergyHematology	2020	28
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro Mariko Noguchi‐Sasaki, Tetsuhiro Soeda, Atsunori Ueyama, TH Open ImmunohematologyImmunologyImmune SystemThrombin Generation AssaysImmunotherapy	2018	23
Emicizumab Improves Ex Vivo Clotting Function in Patients with Mild/Moderate Hemophilia A Yuto Nakajima, Keiji Nogami, Koji Yada, Thrombosis and Haemostasis	2020	15
Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A Masahiro Takeyama, Shoko Furukawa, Koji Yada, Thrombosis and Haemostasis	2021	13
Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice Yusuke Sasaki, Mariko Noguchi‐Sasaki, Yukari Matsuo-Tezuka, International Journal of Hematology InflammationIntensive SuppressionIron MetabolismHematologyEpoetin Beta Pegol	2014	12
Visualization of<sup>57</sup>Fe-Labeled Heme Isotopic Fine Structure and Localization of Regions of Erythroblast Maturation in Mouse Spleen by MALDI FTICR-MS Imaging Makoto Kihara, Yukari Matsuo-Tezuka, Mariko Noguchi‐Sasaki, Journal of the American Society for Mass Spectrometry	2017	10

Page 1